The law regulating clinical medical research established controls on conducting medical research, as it stipulated that conducting medical research may not be limited to a certain group of people or to groups entitled to additional protection unless the research is necessary and related to their diseases, and with justifications If the medical research is on one of the categories entitled to additional protection, consent must be obtained from the parents, or whoever has the guardianship or guardianship in the event of the death of one or both parents, or from the legal representative, and that All in accordance with the controls and procedures determined by the executive regulations of this law.
Before starting any medical research, there must be a protocol reviewed and approved by the competent institutional committee, provided that its approval is final in cases other than clinical medical research referred to in the following paragraph. .
The approval of the Egyptian Medicines Authority and the approval and accreditation of the Supreme Council are required in the case of clinical medical research that includes the use of novel or biological pharmaceutical compounds, new indications for use, or forms, medical supplies or devices that have not been used in the human body before, and have not obtained the approval of the international bodies that specify them. The executive regulations of this law are to be tested in reference countries at the same time.